scispace - formally typeset
U

Ursula Schmidt-Erfurth

Researcher at Medical University of Vienna

Publications -  703
Citations -  34745

Ursula Schmidt-Erfurth is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Macular degeneration & Optical coherence tomography. The author has an hindex of 82, co-authored 638 publications receiving 28143 citations. Previous affiliations of Ursula Schmidt-Erfurth include University of Vienna & Yahoo!.

Papers
More filters
Journal ArticleDOI

The role of the optical coherence tomography in identifying shape and size of idiopathic epiretinal membranes

TL;DR: In this article, the role of the preoperative retinal thickness map (RTM) of the optical coherence tomography (OCT) in identifying the shape and the size of the idiopathic epiretinal membranes (iERM) was investigated.
Book ChapterDOI

Modeling Disease Progression In Retinal OCTs With Longitudinal Self-Supervised Learning

TL;DR: In this article, a self-supervised approach is proposed to model disease progression from longitudinal retinal optical coherence tomography (OCT) images, which can be used to predict the onset of an advanced stage of age-related macular degeneration within a given time interval based on a single OCT scan.
Journal ArticleDOI

Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.

TL;DR: After stabilization of the disease, a monthly follow-up of optical coherence tomography and re-treatment based on morphologic, clinical, and vision outcomes may increase the efficacy in patients with neovascular related macular degeneration under anti–vascular endothelial growth factor treatment.
Journal ArticleDOI

[Choroidal changes after photodynamic therapy (PDT). A two-year follow-up study of 38 patients].

TL;DR: The results show that photodynamic therapy is an alternative treatment in age-related macular degeneration with choroidal, subfoveal neovascularisation with choreological changes associated with this therapy and may be helpful to choose treatment intervals.